CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
FreeStyle Navigator Continuous Glucose Monitoring Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01214824
NCT01214824N/ACompleted
CompareCT.gov

Use of the FreeStyle Navigator Continuous Glucose Monitoring System to Enhance Education and Glycaemic Control

Abbott Diabetes Care·interventional·Posted Oct 5, 2010·Updated Jul 2, 2013

In Brief

A clinical study evaluating FreeStyle Navigator Continuous Glucose Monitoring System for Diabetes Mellitus. Completed, enrolled 32 participants across 5 sites.

Detailed Summary

To demonstrate that in patients with persistent poorly controlled diabetes, short/intermittent use of continuous glucose monitoring can driver better longer-term glycaemic control and HbA1c.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus
CountriesUnited Kingdom
CollaboratorsLiverpool University Hospitals NHS Foundation Trust, National Heatlh Service Ayrshire and Arran, NHS Lothian, National Health Service, United Kingdom, Cardiff and Vale University Health Board

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedOct 5, 2010
Enrollment StartNov 1, 2010
Primary CompletionFeb 1, 2012
Study CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 15.7 years ago

Interventions

FreeStyle Navigator Continuous Glucose Monitoring Systemdevice

Six x 5 day wears of the continuous glucose monitoring device. Two of the 6 wears will be using a masked device (1 at the start and 1 at the end of the study).